We are requesting continued funding of this training grant to support pre- and postdoctoral fellows in biomedical aspects of drugs of abuse. This training program has been very successful in that the trainees supported have continued to work in drug abuse related research projects. Many of them are now NIDA grantees. The major emphasis of this program continues to be pharmacological. We have expanded the faculty to broaden the exposure of our trainees to important new research areas. The faculty of this program now includes experts in AIDS, forensic toxicology, and molecular biology, as well as the pharmacologists who continue to make important contributions to the study of the abuse potential and mechanism of action of opiates, cannabinoids, phencyclidine, nicotine and other abused drugs. The organic chemistry component continues to be Important. The predoctoral training program is a rigorous graduate program in pharmacology. The program is characterized by two years of essential course work, but the major emphasis is placed on research. The research projects of the fellows supported by this training program will be directed toward elucidating the abuse potential, mechanisms of action and pharmacological properties of drugs of abuse. The faculty of this program are experienced and funded researchers in this important area. Other faculty in the pharmacology department and selected faculty from other departments will also contribute to the overall education of the trainees. Postdoctoral trainees will concentrate on research throughout their training. They will work in close association with their faculty advisor who advises them on research, teaching, professionalism of a drug abuse researcher and all aspects of becoming a productive independent researcher. Opportunities for clinical exposure exists in the drug abuse clinic at the VA and in our hospital. The predoctoral trainees will have completed at least one year of graduate training before being accepted into this program. The postdoctoral trainees will all have defended their theses in pharmacology or a related discipline prior tome beginning of their training in this program. This has been a very productive training program with plenty of applications. The laboratories are well-equipped with modern instrumentation for biomedical, behavioral and classical pharmacological studies, as well as organic chemistry. Modem ALAAC approved animal quarters exist. Desk space for trainees (offices for postdocs), as well access to personal computers is available. The medical library and computer center are within one block.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Institutional National Research Service Award (T32)
Project #
5T32DA007027-23
Application #
2713094
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Lawrence, Diane M
Project Start
1976-07-01
Project End
2001-06-30
Budget Start
1998-07-01
Budget End
1999-06-30
Support Year
23
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Wilkerson, Jenny L; Curry, Zachary A; Kinlow, Pamela D et al. (2018) Evaluation of different drug classes on transient sciatic nerve injury-depressed marble burying in mice. Pain 159:1155-1165
Hill, Rob; Disney, Alex; Conibear, Alex et al. (2018) The novel ?-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception. Br J Pharmacol 175:2653-2661
Kyte, S Lauren; Toma, Wisam; Bagdas, Deniz et al. (2018) Nicotine Prevents and Reverses Paclitaxel-Induced Mechanical Allodynia in a Mouse Model of CIPN. J Pharmacol Exp Ther 364:110-119
Johnson, Amy R; Banks, Matthew L; Selley, Dana E et al. (2018) Amphetamine maintenance differentially modulates effects of cocaine, methylenedioxypyrovalerone (MDPV), and methamphetamine on intracranial self-stimulation and nucleus accumbens dopamine in rats. Neuropsychopharmacology 43:1753-1762
Hill, Rob; Dewey, William L; Kelly, Eamonn et al. (2018) Oxycodone-induced tolerance to respiratory depression: reversal by ethanol, pregabalin and protein kinase C inhibition. Br J Pharmacol 175:2492-2503
Jacob, Joanna C; Sakakibara, Kensuke; Mischel, Ryan A et al. (2018) Ethanol Reversal of Oxycodone Tolerance in Dorsal Root Ganglia Neurons. Mol Pharmacol 93:417-426
Kyte, S Lauren; Gewirtz, David A (2018) The Influence of Nicotine on Lung Tumor Growth, Cancer Chemotherapy, and Chemotherapy-Induced Peripheral Neuropathy. J Pharmacol Exp Ther 366:303-313
Mischel, Ryan A; Dewey, William L; Akbarali, Hamid I (2018) Tolerance to Morphine-Induced Inhibition of TTX-R Sodium Channels in Dorsal Root Ganglia Neurons Is Modulated by Gut-Derived Mediators. iScience 2:193-209
Shin, Myungsun; Snyder, Helena W; Donvito, Giulia et al. (2018) Liposomal Delivery of Diacylglycerol Lipase-Beta Inhibitors to Macrophages Dramatically Enhances Selectivity and Efficacy in Vivo. Mol Pharm 15:721-728
Lazenka, Matthew L; Moerke, Megan J; Townsend, E Andrew et al. (2018) Dissociable effects of the kappa opioid receptor agonist nalfurafine on pain/itch-stimulated and pain/itch-depressed behaviors in male rats. Psychopharmacology (Berl) 235:203-213

Showing the most recent 10 out of 339 publications